Proteomics, Transcriptomics, and Phosphoproteomics Reveal the Mechanism of Talaroconvolutin-A Suppressing Bladder Cancer via Blocking Cell Cycle and Triggering Ferroptosis
Molecular & Cellular Proteomics · 2023-12 · 22 (12) · 100672
DOI: 10.1016/j.mcpro.2023.100672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2023-12. Verfasst von Yong Xia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Precision Medicine Laboratory for Chronic Non-communicable Diseases of Shandong Province, Institute of Precision Medicine, Jining Medical University,…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Ferroptosis, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taishan Scholar Project of Shandong Province, Guangxi Key Research and Development Program, Taishan Scholar Foundation of Shandong Province.
Abstract (Originalsprache)
Talaroconvolutin-A (TalaA) is a compound from the endophytic fungus T. convolutispora of the Chinese herbal medicine Panax notoginseng. Whether TalaA exerts anticancer activity in bladder cancer remains unknown. Using CCK8 assay, EdU staining, crystal violet staining, flow cytometry, living/dead cell staining, and Western blotting, we studied the anticancer activity of TalaA in vitro. Moreover, we performed xenograft tumor implantation. The antitumor effects were evaluated through H&E and immunohistochemistry staining. Proteomics was conducted to detect changes in the protein profile; transcriptomics was performed to detect changes in mRNA abundance; phosphoproteomics was used to detect changes in protein phosphorylation. TalaA inhibited tumor cell proliferation, DNA replication, and colony formation in a dose-dependent manner in bladder cancer cells. The IC50 values of TalaA on SW780 and UM-UC-3 cells were 5.7 and 8.2 μM, respectively. TalaA (6.0 mg/kg) significantly repressed the growth of xenografted tumors and did not affect the body weight nor cause obvious hepatorenal toxicity. TalaA arrested the cell cycle by downregulating cyclinA2, cyclinB1, and AURKB and upregulating p21/CIP. TalaA also elevated intracellular reactive oxygen species and upregulated transferrin and heme oxygenase 1 to induce ferroptosis. Moreover, TalaA was able to bind to MAPKs (MAPK1, MAPK8, and MAPK14) to inhibit the phosphorylation of ∗SP∗ motif of transcription regulators. This study revealed that TalaA inhibited bladder cancer by arresting cell cycle to suppress proliferation and triggering ferroptosis to cause cell death. Conclusively, TalaA would be a potential candidate for treating bladder cancer by targeting MAPKs, suppressing the cell cycle, and inducing ferroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Precision Medicine Laboratory for Chronic Non-communicable Diseases of Shandong Province, Institute of Precision Medicine, Jining Medical University, Jining, Shandong, China. Electronic address: xiayong@mail.jnmc.edu.cn.
- Department of Pathology, Jining No. 1 People's Hospital, Jining, Shandong, China.
- School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, China.
- Precision Medicine Laboratory for Chronic Non-communicable Diseases of Shandong Province, Institute of Precision Medicine, Jining Medical University, Jining, Shandong, China.
- College of Basic Medicine, Jining Medical University, Jining, Shandong, China.
- School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, China. Electronic address: yxl19830915@163.com.
Förderung
- Taishan Scholar Project of Shandong Province
- Guangxi Key Research and Development Program
- Taishan Scholar Foundation of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Xia, Y., Xiang, L., Yao, M., Ai, Z., Yang, W., Guo, J., Fan, S., Liu, N., & Yang, X. (2023). Proteomics, Transcriptomics, and Phosphoproteomics Reveal the Mechanism of Talaroconvolutin-A Suppressing Bladder Cancer via Blocking Cell Cycle and Triggering Ferroptosis. Molecular & Cellular Proteomics, 22(12), 100672. https://doi.org/10.1016/j.mcpro.2023.100672
Vancouver
Xia Y, Xiang L, Yao M, Ai Z, Yang W, Guo J, et al. Proteomics, Transcriptomics, and Phosphoproteomics Reveal the Mechanism of Talaroconvolutin-A Suppressing Bladder Cancer via Blocking Cell Cycle and Triggering Ferroptosis. Molecular & Cellular Proteomics. 2023;22(12):100672. doi:10.1016/j.mcpro.2023.100672
BibTeX
@article{Xia2023,
author = {Xia, Yong and Xiang, Longquan and Yao, Ming and Ai, Zhiying and Yang, Wei and Guo, Jianhua and Fan, Shuhao and Liu, Ning and Yang, Xiaolong},
title = {Proteomics, Transcriptomics, and Phosphoproteomics Reveal the Mechanism of Talaroconvolutin-A Suppressing Bladder Cancer via Blocking Cell Cycle and Triggering Ferroptosis},
journal = {Molecular & Cellular Proteomics},
year = {2023},
volume = {22},
number = {12},
pages = {100672},
doi = {10.1016/j.mcpro.2023.100672}
}
EUVIMED